Lv41
464 积分 2021-11-23 加入
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
5小时前
待确认
Targeting airway inflammation and dysfunction in non-cystic fibrosis bronchiectasis with KIT2014 inhaled peptide
28天前
已关闭
A Structure Dosage Form Approach for Solubility and Dissolution Rate Enhancement
1个月前
已关闭
New limits proposed for the management of non-mutagenic impurities
3个月前
已完结
Risk based qualification of non-mutagenic impurities
3个月前
已关闭
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
4个月前
已完结
Route Development toward a Pyrazine Building Block to Enable Early Scale-Up Campaigns
4个月前
已完结
Industry guidance on container closure integrity strategies for difficult-to-test parenteral products (DTPs)
4个月前
已关闭
Industry guidance on container closure integrity strategies for difficult-to-test parenteral products (DTPs)
4个月前
已关闭
A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman primates and human lung tissue
6个月前
已关闭
皖公网安备34019202002308
